ACORDA THERAPEUTICS Stock Price
$32.61 
Change:
-0.54 -0.81% Volume:
7,387
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 33.15 | Todays Low: 32.61 | Open: 33.15 | Last Close: 32.97
52 Wk High: 40.8 | 52 Wk Low: 21.06 | Todays Pivot: 32.88 | Pre market open: 40.79
Sector:
Online News For Acorda Therapeutics
|
Acorda Therapeutics Announces Issuance of Additional US Patent for AMPYRA ... - The Herald | HeraldOnline.com
Mon, 20 May 2013 11:16ARDSLEY, N.Y. — Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Application No. 8,440,703 (“the '703 patent”) entitled “Methods of Using Sustained Release ...
|
|
ACORDA THERAPEUTICS INC : Acorda Therapeutics' Legal Department ... - 4-traders (press release)
Fri, 17 May 2013 11:38ARDSLEY, N.Y.--(BUSINESS WIRE)--May. 17, 2013-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Company's Legal department has been selected by Corporate Counsel magazine as one of the four "Best Legal Departments 2013." ...
|
|
Acorda Therapeutics: Scrappy But Savvy - Law.com - Corporate Counsel
Wed, 15 May 2013 14:58By 2010 Acorda Therapeutics Inc.'s Hawthorne, New York, headquarters was bursting at the seams. With 300 employees, and just a single conference room, its lawyers later joked about having to put up a temporary wall whenever two meetings needed to be ...
|
|
Acorda Therapeutics, Inc. (ACOR): Today's Most Compelling Stock Buy - NASDAQ
Mon, 13 May 2013 16:16Acorda Therapeutics Inc (ACOR) is our most compelling buy today due to the fact that it is a top- rated stock (in terms of earnings strength and company/industry performance) in our top rated industry, Biotechnology. Biotechnology has been on fire this ...
|
|
ALM's Corporate Counsel Names "Best Legal Departments" Winners: Acorda ... - MarketWatch (press release)
Wed, 15 May 2013 15:50NEW YORK, May 15, May 15, 2013 (GLOBE NEWSWIRE via COMTEX) -- ALM's Corporate Counsel today announced the winners of its 2013 Best Legal Departments competition: Acorda Therapeutics Inc., Bristol-Myers Squibb, Caesars Entertainment ...
|
|
ACORDA THERAPEUTICS INC : Acorda Therapeutics to Present at the UBS ... - 4-traders (press release)
Wed, 15 May 2013 11:07Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., Acorda's President and Chief Executive Officer, will present at the UBS Global Healthcare Conference on Wednesday, May 22 at 10:30 a.m. at the Sheraton New York Hotel ...
|
ACOR Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Acorda Therapeutics quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ACOR to choose from. Visit here to build your stock quote widget »